title: Can the routine treatment of Graves' orbitopathy be efficiently supplemented by the administration of Venalot?
authors.affiliation: Abteilung Innere Medizin I, Universitätsklinik, Heidelberg, FRG.
authors.forename: K
authors.initials: K
authors.lastname: Frank
authors.forename: G
authors.initials: G
authors.lastname: Ding
authors.forename: F
authors.initials: F
authors.lastname: Raue
authors.forename: R
authors.initials: R
authors.lastname: Ziegler
mesh_terms: D002986:Clinical Trials as Topic; D003374:Coumarins / Q000627:therapeutic use*; D004311:Double-Blind Method; D004338:Drug Combinations / Q000627:therapeutic use; D004700:Endocrine System Diseases / Q000188:drug therapy; D005500:Follow-Up Studies; D006111:Graves Disease / Q000188:drug therapy* / Q000532:radiotherapy; D006801:Humans; D006896:Hydroxyethylrutoside / Q000031:analogs & derivatives* / Q000627:therapeutic use; D012431:Rutin / Q000031:analogs & derivatives*; D013960:Thyroid Function Tests
chemical_list: D003374:Coumarins; D004338:Drug Combinations; D006896:Hydroxyethylrutoside; C013731:Venalot; D012431:Rutin